Medicines Discovery Catapult

Reshaping Discovery Together

Explore
decorative image
Catapult Network Logo

Part of the Catapult Network

Established by Innovate UK

Non profit Icon

Independent, Not-for-Profit Organisation

Pioneering the next generation of approaches and technologies

Orion Pill Icon

Industrialising and Driving Adoption

Of new scientific tools and modern techniques for discovering medicines

Tree Icon

Supporting the Drug Discovery Industry

SMEs and innovators to deliver growth for the drug discovery economy

Building Icon

Leveraging UK Infrastructure

Connecting the community

Microscope Icon

Tackling Industry-led Challenges

That limit today’s discovery process

top shape
left shape
right shape

Our Impact

See the impact Medicines Discovery Catapult is having in drug discovery, as we work to reshape drug discovery for patient benefit.

Our Impact

Reshaping Medicines Discovery...

It's ambitious, it's achievable

How We Work

Investing Funding into SMEs

Investing Funding into SMEs

Leveraged

£600m

Private Investment

Products to Market

Products to Market

3

Partner Products to Market

Grant Income Raised

Grant Income Raised

£67m

Grant Income Raised in collaboration with MDC

Partnered Projects

Partnered Projects

234

Partnered Projects

Supported Companies

Supported Companies

209

Companies Supported in their Products Development

Compounds Into the Clinc

Compounds Into the Clinc

4

Compounds Supported into the clinic

Investing Funding into SMEs

Investing Funding into SMEs

Leveraged

£600m

Private Investment

Products to Market

Products to Market

3

Partner Products to Market

Grant Income Raised

Grant Income Raised

£67m

Grant Income Raised in collaboration with MDC

Partnered Projects

Partnered Projects

234

Partnered Projects

Supported Companies

Supported Companies

209

Companies Supported in their Products Development

Compounds Into the Clinc

Compounds Into the Clinc

4

Compounds Supported into the clinic

News

Our latest press releases, media appearances and news commentary.

AllNews

Loading...